Skip to content

A cross-sectional survey on herb-drug interaction between Giloy and conventional medications along with its in vitro estimation by cytochrome P-450 enzymes

A cross-sectional survey to study the effect of concomitant use of Guduchi [Tinospora cordifolia (WILLD) HOOK. F. & Thomas] with conventional drugs and in-vitro studies on its interaction with anti-diabetic drugs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/052854
Enrollment
300
Registered
2023-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: NIL : No intervention or comparator, only observational study

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients of Diabetes Mellitus who have been taking Guduchi as a supportive medication (either as a single herb or in formulation) along with commonly prescribed antidiabetic drugs. b) Diagnosed patients of Yakrut vikara (liver disorders), Vatarakta (gout) and Jwara (fever) who are taking Guduchi (either in single or combination) along with modern medicaments. c) Age â?? 18 â?? 80 years of both sexes.

Exclusion criteria

Exclusion criteria: a) Pregnant women b) Lactating mothers c) Paediatric populations d) Patients suffering from other life-threatening diseases such as cancer, stroke, tuberculosis etc. e) Patients of other metabolic disorders excluding diabetes

Design outcomes

Primary

MeasureTime frame
To know the patterns of concomitant use of Guduchi along with conventional medications.Timepoint: 1 year 3 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactNiranjan Ram

All India Institute of Ayurveda

tnesari@hotmail.com9958817145

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026